Lung cancer continues to be a malignant tumor with high mortality. Two obstacles interfere
with curative therapy of lung cancer:(i) poor diagnosis at the early stages, as symptoms are …

Lung cancer (LC) is one of the leading causes of cancer occurrence and mortality
worldwide. Treatment of patients with advanced and metastatic LC presents a significant …

Lung cancer is the second most prevalent cancer and the leading cause of cancer‐related
death worldwide. Surgery, chemotherapy, molecular targeted therapy, immunotherapy, and …

Lung cancer is a leading cause of cancer-related death worldwide, with a very poor overall
five-year survival rate. The intrinsic limitations associated with the conventional diagnosis …

Lung cancer is a significant health problem worldwide. Unfortunately, current therapeutic
strategies lack a sufficient level of specificity and can harm adjacent healthy cells …

Lung cancer is an umbrella term for a subset of heterogeneous diseases that are collectively
responsible for the most cancer-related deaths worldwide. Despite the tremendous progress …

Lung cancer is the second most common cancer and the leading cause of death in both men
and women in the world. Lung cancer is heterogeneous in nature and diagnosis is often at …

Carcinoma of the lungs is among the most menacing forms of malignancy and has a poor
prognosis, with a low overall survival rate due to delayed detection and ineffectiveness of …

Intrinsic anticancer drug resistance appearing prior to chemotherapy as well as acquired
resistance due to drug treatment, remain the dominant impediments towards curative cancer …

Lung cancer is the leading cause of cancer mortality worldwide. Owing to a lack of early-
stage diagnosis, most lung cancers are detected in advanced stages, limiting the available …